CAT No: AAD-347
CAS No:1043043-79-3
Synonyms/Alias:1043043-79-3;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(tert-butoxy)-2,6-dimethylphenyl)propanoic acid;Fmoc-Tyr(2,6-Me2,4-tBu)-OH;O-(t-Butyl)-N-Fmoc-2,6-dimethyl-L-Tyrosine;(2S)-3-[2,6-dimethyl-4-[(2-methylpropan-2-yl)oxy]phenyl]-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid;Fmoc-2,6-Dimethyl-L-Tyr(tert-butyl)-OH;Fmoc-Dmt(tBu)-OH;MFCD20133793;AT36506;O-(1,1-Dimethylethyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-2,6-dimethyl-L-tyrosine;AS-83802;CS-0439166;(2S)-3-[4-(tert-butoxy)-2,6-dimethylphenyl]-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanoic acid;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(tert-butoxy)-2,6-dimethylphenyl)propanoicacid;
4. TMEM16F and dynamins control expansive plasma membrane reservoirs
5. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.